The aim of this study is to describe the essential characteristics of a family affected by the newly-described proximal myotonic myopathy (PROMM). The clinical, laboratory and genetic findings are described and compared with those reported in the literature, and the clinical spectrum of the manifestations that are similar to but distinct from myotonic dystrophy (MD) is also explored. This has practical implications because the cases so far described suggest that the long-term prognosis of patients with PROMM seems to be more favourable than that of patients with MD.
Introduction
Myotonic dystrophy (MD) is an autosomal dominant inherited disorder characterized by a distinct pattern of weakness of the facial and anterior neck muscles and a distally pronounced muscle weakness of the limbs, associated with myotonia and multisystem involvement mainly concerning the cardiac conduction system, gonadal, thyroid and pancreatic functions, and intellectual function [5, 9, 16] . Anticipation (that is, increasing clinical severity and an earlier age of onset in subsequent generations) is another clinical hallmark of MD [1, 2] . Four years ago, the myotonic dystrophy gene was isolated on chromosome 19 [3, 7] and found to code for a protein kinase; the gene contains an unstable trinucleotide repeat (CTG), which varies in size from 5 to 37 units in normal alleles. Myotonic patients with the clinical presentation described above show an expansion of the repeated sequence that may involve from 50 to several thousand units [21] . The relationship between clinical symptoms and the size of the CTG trinucleotide repeat has been a matter of debate because the size of the expansion varies from tissue to tissue; however, there is a direct correlation between the degree of expansion and muscular disability [11] and an inverse correlation with age at disease onset. Other symptoms such as myotonia and cataracts do not correlate with the size of the repeat and controversial results have been obtained on cardiac involvement and expansion by different authors [8, 10, 14] . Muscle biopsy shows muscle atrophy, selectively This study has been partially funded (60%) by a MURST grant.
Received 5 January 1996 -Accepted 7 June t996 involving type I fibers in about 50% of cases, and increased numbers of central nuclei, ring fibers and sarcoplasmic masses are typical [6] . The diagnosis of MD is based on a clinical evaluation of the multisystem involvement, dominant inheritance, myotonia and distal muscle weakness, associated with the muscle biopsy findings described above and the demonstration of CTG expansion in peripheral blood and muscle tissue. Thornton et al. [28] described patients with characteristic features of myotonic dystrophy as having frontal balding, cataracts, mild cardiac conduction abnormalities, myotonia and only slight proximal muscle weakness without distal atrophy, and normal deep tendon reflexes. The results of muscle biopsy were consistent with myotonic dystrophy, and showed increased internal nuclei, pyknotic nuclear clumps and numerous atrophic fibers of both fiber types. However, no trinucleotide repeat expansion was found and it was concluded that the demonstration of a normal number of CTG repeats for the myotonic dystrophy gene did not exclude the diagnosis of myotonic dystrophy. More recently, a number of authors [13, 15, 17, 25, 26] have described the clinical features of a multisystem disorder that is similar to, but distinct from myotonic dystrophy insofar as the wasting and weakness were mainly proximal rather than distal in all patients, deep tendon reflexes were normal, anticipation was not a prominent feature in any of the families and cardiac conduction was only mildly affected in most patients; the results of muscle biopsy were non-specific, and genetic analysis excluded any linkage to chromosome 19. Consequently, this is now considered a new myotonic disorder to be re- ferred to as PROMM (proximal myotonic myopathy). The aim of this study is to report personal experience of this new myotonic disorder, and to compare the clinical, laboratory and genetic findings in patients with those reported in literature. The clinical spectrum of the manifestations underlying those aspects that are similar to but distinct from myotonic dystrophy is also highlighted. This is important because, on the basis of the cases reported so far, the long-term prognosis of patients with PROMM seems to be more favourable than that of patients with MD.
Patients
Four patients (mean age 47.6 years; range 32-71) have been clinically investigated; most of the members of the family have undergone linkage analysis but have never been physically examined because they have not suffered any complaints. The onset of symptoms in the symptomatic individuals occurred when they were between 16 and 27 years of age, and the disease was transmitted both paternally and maternally. In particular, one patient (71 years old) has mainly proximal weakness with normal deep tendon reflexes; another (37 years old) only has more proximal weakness; the third patient (43 years old) has no weakness, but does have proximal atrophy, scapular winging and calf hypertrophy; and the youngest patient (32 years old) has mild proximal weakness with slight proximal atrophy and calf hypertrophy. One of the four patients has prominent grip myotonia, which clearly improves after repeated muscle contractions (warm-up). The genetic, clinical and laboratory findings in patients will be discussed in more detail in the next sections, and then compared with those published in the literature.
Genetics
The gene responsible for the PROMM phenotype is.still unknown; large families are required in order to be able to track a specific trait in relation to marker genes of known location for linkage analysis. This has so far been done for only 4 families, including that of the patients described in this report [15, 25, 26] , because the other families were not large enough to permit this type of genetic investigation.
As lJreviously described, DNA was extracted from the peripheral blood leukocytes and skeletal muscle of all of the patients belonging to our family in order to determine the size of the CTG repeat by means of Southern blot and PCR reactions [20] . Genetic linkage was analyzed in order to test the hypothesis that the disease allele is linked to the myotonic dystrophy locus (Marker Mfd5), and an analysis was also made of the marker closely linked to the chromosome 17 voltage-gated sodium channel locus (HGH2) known to cause two other myotonic disorders: hyperkalemic periodic paralysis and paramyotonia congenita [15, 22, 23, 24, 27] . Linkage to CICN1 on chromosome 7q has been excluded in 3 of the 4 families for which linkage analysis was possible [15, 25, 26] . Linkage to the genes on chromosomes 7, 17 and 19, which respectively cause myotonia congenita [12] , hyperkalemic periodic paralysis and paramyotonia congenita [23, 24, 27] , and myotonic dystrophy has been excluded in all of the PROMM families described so far.
No linkage analysis has been made of the family of only one of the described patients with an abnormal CTG expansion and PROMM phenotype [13] .
Clinical overview A summary is made of the clinical findings relating to the patients with a PROMM phenotype considered in this report and the other families so far described in the literature [13, 15, 17, 25, 26] . Table I shows the core differences between the PROMM and MD phenotypes. A total of about 103 patients from 27 unrelated families (22 families, including the family of this report, with auto- somal dominant inheritance and 5 isolated cases) have been investigated by different authors. Their age at the onset of weakness varied from teenage to adulthood; in other patients, cataracts were the first manifestation of this disorder.
Myotonia
Almost all of the patients in family had a history of clinical myotonia, which was intermittent, asymmetric and worsened by exposure to the cold. In one patient, this was experienced as a stepwise, jerky relaxation of the fingers (especially of the index finger and thumb) that was indistinguishable from the myotonia present in MD (Fig.  la) ; there was a clear "warm-up" phenomenon after repeated muscle contractions so that the time taken to extend the fingers from a flexed position in a fist in one minute was greatly reduced (Fig. 1 b) . It has been reported in the literature that, in some patients, myotonia was experienced as a stiffness in the legs that was occasionally sufficient to make them fall when they attempted to run [25] , whereas others complained of myalgia. Myotonic discharges during EMG recordings were present in all of our four patients, even in those who did not experience clinical myotonia; once again, these were indistinguishable from those observed in MD. There were only mild myopathic changes in the EMG pattern, but the changes are more myotonic that myopathic in PROMM than in MD patients. Our EMG findings agree with those reported by other authors, who have described myotonic discharges even in affected individuals without obvious clinical myotonia. However, these myotonic discharges are small and difficult to detect.
Weakness
MD with CTG expansion is traditionally characterized by distal weakness and atrophy, with functional impairment of the fingers and feet. The patients tend to develop a bilateral foot-drop that interferes with their ability to walk without aid (Fig. 2b) , and this is associated with a gradual loss of deep tendon reflexes. Both the weakness and the atrophy have a progressive course, and are often the first manifestations of MD. In addition to distal limb weakness, MD patients also experience weakness in the anterior neck and facial muscles, which gives rise to the typical hatchet-face. On the other hand, Thornton et al. [28] have described three patients from two families who experienced late-onset mild proximal weakness without any CTG expansion, but who had clinical and histological characteristics that were compatible with a diagnosis of MD.
A characteristic clinical feature of our patients is the presence of proximal without distal weakness at onset, in the absence of distal wasting and with normal deep tendon reflexes. Two of patients had hypertrophy of the calf muscles in comparison with the distal wasting of MD patients with CTG expansion (Fig. 2a) . Proximal weakness was revealed in some of patients only by the presence of scapular winging; the patients often complained of greater generalized fatigue rather than focally distributed muscle weakness. The same findings have been observed in the other PROMM patients described so far.
Muscle pain
This is seldom complained of by MD patients, who at most complain of a difficulty in relaxing after a contraction and generalized muscle stiffness. However, PROMM patients often complain of muscle pain that is distinct from the unpleasant sensation on relaxation and is therefore not related to myotonic stiffness. Some patients experience spontaneous myalgias, which are most apparent at rest and mainly occur in the thighs or shoulder girdle. This is not a constant finding and does not seem to be exacerbated by specific manoeuvres or strenuous exercise. In our experience, only one young patient has complained of spontaneous lower limb myalgias that are refractory to aspirin and non steroidal anti-inflammatory drugs.
Myoglobinuria
The literature contains descriptions of only two PROMM patients who have experienced an increase in serum CK levels, associated with severe myalgia and rhabdomyolysis, that gave rise to myoglobinuria after unusual ath- letic exercise in one patient and after minor surgery in another [26] . Linkage to chromosome 19 had been excluded, so this was probably not due to one of the known mutations on the ryanodine receptor [18] . Susceptibility to malignant hyperthermia has been described in patients with MD [6] , as in those with other myopathies (ranging from increased CK levels to more definite clinical phenotypes of Duchenne and Becker muscular dystrophies), and the same precautions should be taken in MD and PROMM patients before any surgical intervention requiring general anaesthesia.
Cataracts
Early-onset bilateral cataracts are a constant feature in all PROMM patients, including our cases, and these are indistinguishable from the posterior capsular lens opacities found in patients with MD. This is often the first manifestation of the disease.
Cardiac involvement
Cardiac conduction system abnormalities and cardiac muscle dysfunction are a frequent and well-documented finding in MD [4, 19] . Cardiac dysfunction usually appears several years after the onset of neuromuscular symptoms, but may occasionally be the first manifestation of the disease. The cardiac findings in MD include conduction abnormalities with or without arrhythmias, dilated cardiomyopathy, mitral valve prolapse and sudden death [4] . In the four patients studied by means of standard and 24-h ECG recordings, echocardiography and cardiac MRI, no significant conduction abnormalities were found and there was no sign of the fatty infiltration previously revealed by MRI in MD patients [4] . One of the characteristics of PROMM patients is a milder degree of cardiac involvement, which also occurs less frequently than the 62-75% of cases observed in MD patients [19] . Of the PROMM patients described so far, only two had early-onset cardiac symptoms, which required the implantation of a pace-maker in one and caused a cardiac arrest in the other [26] .
Laboratory findings
Blood studies There is no peripheral diagnostic marker of MD or PROMM phenotypes, although the CK levels of patients are usually mildly high (2-3x) and have been recorded as reaching 35x normal values in other reports [26] .
Many of the PROMM patients tested have also been found to have high levels of gamma-glutamyltransferase, even with normal levels of alanine aminotransferase and aspartate aminotransaminase, and in the absence of a history of alcohol abuse or other liver disease. An increase in gamma-glutamyltransferase is also described in MD patients.
the presence of scattered, small atrophic fibers, but the significance of these findings is unclear in view of the absence of fiber type grouping or any other signs of chronic denervation.
Muscle biopsy
The findings of the muscle biopsies performed in patients are non-specific: mild to moderate central nuclei and some atrophy of type II fibers or type II fiber predominance [t5, 25] . The mosaic pattern of the fibers at myofibrillar ATPases of various pH is normal without any evidence of type grouping or other signs of denervation ( Fig. 3a and 3b) . No deficiency in 2A or 2B fibers has been observed, thus excluding myotonic disorders such as Thomsen's or Becker's disease (chloride channel disorder). Ringbinden (Fig. 3d) , subsarcolemmal masses, a greater increase in central nuclei ( Fig. 3c) , nuclear clumps and selective type I fiber atrophy have been found in patients with MD [29] . Muscle biopsy in our and other PROI~IM patients reveals non-specific myopathy. There have been reports of
Comment
The diagnosis of MD is now based on the genetic analysis of CTG repeat expansion on chromosome 19 when patients have dominantly'inherited multisystem involvement, including cardiac conduction abnormalities, gonadal dysfunction, cataracts and mental disturbances associated with distal weakness, wasting and myotonia [6, 9, 16] . A small number of MD patients without CTG expansion have been described with unusual clinical features, such as the lack of anticipation, proximal rather than distal weakness and well-developed rather than atrophied muscles, but their overall clinical pictures and the laboratory findings were consistent with MD [28] . So far, about 100 patients from 27 families have been described as having certain clinical characteristics typical of d MD, including myotonia, cataracts, weakness and other systemic abnormalities [13, 15, 17, 25, 26] ; however, the patients with the phenotype referred to as proximal myotonic myopathy (PROMM) have proximal rather than distal muscle involvement, the facial muscles are spared, and there is no striking muscular atrophy or significant mental disturbance. Muscle biopsy findings are non-specific and, in a few cases, may even be similar to, although milder than those observed in patients with MD [13] . DNA analysis in PROMM patients does not show an abnormal expansion of CTG repeats of the MD gene and linkage analysis of the four families large enough to allow this type of investigation has shown that there is no linkage to the MD locus on chromosome 19. For those patients with a PROMM phenotype in whom genetic study was limited to CTG expansion analysis, one might consider the possibility of a somatic cell mutation leading to CTG repeat expansion in selected tissues, or mutations other than trinucleotide repeat expansion such as point mutations or deletions within the MD gene [28] ; however, no examples of such mutations have yet been found. In any case, linkage to the MD locus on chromosome 19 has been excluded in four families [15, 25, 26] , thus indicating that families with a PROMM phenotype are genetically distinct from those with an MD phenotype. Linkage genetic analysis of the whole genome of large and informative families is currently being undertaken in order to localize and identify the gene locus for PROMM. The similarities between the PROMM and MD phenotypes (see Table I ) indicate that there must be a common pathway responsible for the core clinical features of these disorders: myotonia, cataracts and weakness. And yet there must also be certain unique factors that account for the differences between PROMM and MD, and which explain the deep muscular atrophy and absence of deep tendon reflexes of MD patients that are so different from the normal or more bulky muscles and normal deep tendon reflexes observed in PROMM patients. Further studies of families with PROMM are necessary in order be able to establish the gene locus, identify its gene product, and increase knowledge of the spectrum of its clinical manifestations. This will not only extend understanding of the pathophysiology of these myotonic disorders, but also has practical significance for the clinician. On the basis of the cases described so far, PROMM patients have a more favourable long-term prognosis than patients with MD, who have more frequent cardiac and respiratory problems. Furthermore, anticipation seems to be a less prominent characteristic of PROMM families and no severe congenital form of the disease has yet been demonstrated. 
Sommario

